BIO-key International, Inc. (BKYI) financial statements (2020 and earlier)

Company profile

Business Address 3349 HIGHWAY 138
WALL, NJ 07719
State of Incorp. DE
Fiscal Year End December 31
SIC 3576 - Computer Communications Equipment (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0014
Cash and cash equivalents 0014
Receivables 2323
Inventory, net of allowances, customer advances and progress billings 1100
Inventory 1100
Other current assets 0000
Other undisclosed current assets 1325
Total current assets: 47513
Noncurrent Assets
Property, plant and equipment 0000
Long-term investments and receivables  12 
Accounts and financing receivable, after allowance for credit loss  12 
Intangible assets, net (including goodwill) 0000
Intangible assets, net (excluding goodwill) 0000
Contract with customer, asset, net 0
Deposits noncurrent assets 0000
Other undisclosed noncurrent assets 78117
Total noncurrent assets: 79127
TOTAL ASSETS: 12161720
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1212
Accounts payable 0001
Accrued liabilities 1101
Interest and dividends payable  10 
Contract with customer, liability0
Other undisclosed current liabilities  110
Total current liabilities: 1222
Noncurrent Liabilities
Total liabilities: 1222
Stockholders' equity
Stockholders' equity attributable to parent, including: 10141518
Common stock 0000
Additional paid in capital 86817877
Accumulated deficit (75)(67)(63)(59)
Warrants and rights outstanding    0
Other undisclosed stockholders' equity attributable to parent  00(0)
Total stockholders' equity: 10141518
TOTAL LIABILITIES AND EQUITY: 12161720

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 4635
Revenue, net435
Cost of revenue
(Cost of Goods and Services Sold)
 (4)(3)(1)(1)
Gross profit: (0)324
Operating expenses (7)(7)(6)(6)
Operating loss: (7)(4)(4)(2)
Nonoperating income (expense) 00 (0)
Investment income, nonoperating 0  0
Interest and debt expense    (0)
Loss from continuing operations before income taxes: (7)(4)(4)(2)
Income tax benefit   0 
Net loss: (7)(4)(4)(2)
Other undisclosed net income attributable to parent    0
Net loss attributable to parent: (7)(4)(4)(2)
Preferred stock dividends and other adjustments (2)(1)(1) 
Other undisclosed net loss available to common stockholders, basic    (0)
Net loss available to common stockholders, basic: (8)(5)(5)(2)
Convertible preferred dividends    (0)
Net loss available to common stockholders, diluted: (8)(5)(5)(2)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (7)(4)(4)(2)
Comprehensive loss, net of tax, attributable to parent: (7)(4)(4)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: